M. Jumayev, “The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance”, GSCMR, vol. 1, no. 2, pp. 184–188, Feb. 2026, doi: 10.5281/zenodo.18796264.